Pharmaceuticals News and Research

RSS

Locus Pharmaceuticals enters into discovery research collaboration with Novartis

Locus Pharmaceuticals announced today that it has entered into a discovery research collaboration with Novartis. Locus will collaborate with Novartis to discover novel chemotypes on targets of interest to Novartis’ select therapeutic areas.

12 Oct 2009

Women who take fertility drugs are at greater risk to develop thyroid cancer

Women who take the most common fertility drugs, progesterone and clomiphene, are at a greater risk to develop thyroid cancer than those who don't, according to a study by the Institute of Cancer Epidemiology, Danish Cancer Society.

12 Oct 2009

Controlled trial comparing Bevacizumab to Ranibizumab finds no difference in efficacy

Investigators from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have shown, at 6 months in a small group of patients, that there is no difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD).

9 Oct 2009

Riley Hospital for Children commences patient enrollment in clinical trial of cystic fibrosis drug

The Riley Hospital for Children Cystic Fibrosis Center is the first site in the nation to enroll patients ages 6-11 for the first part of a 48-week clinical trial of a promising investigational treatment for cystic fibrosis (CF).

9 Oct 2009

Health industries: Changes could kill health reform bill

Insurers and pharmaceutical manufacturers are concerned that changes in a Senate bill could derail efforts — and their agreement — to overhaul the nation's health care system.

9 Oct 2009

CREON Delayed-Release Capsules improves fat absorption in patients with Cystic Fibrosis

Solvay Pharmaceuticals, Inc. announced that Phase III data published in the Journal of Cystic Fibrosis showed that CREON® (pancrelipase) Delayed-Release Capsules, the most prescribed pancreatic enzyme replacement therapy (PERT) in the United States, significantly improves a key measure of fat absorption in patients with CF who suffer from exocrine pancreatic insufficiency (EPI).

9 Oct 2009

Additional Zenvia Phase III results in multiple sclerosis announced by AVANIR

AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR) today announced additional detailed results from the confirmatory double-blind Phase III STAR trial evaluating two doses of the investigational drug Zenvia™ (dextromethorphan/quinidine) compared to placebo in the treatment of pseudobulbar affect (PBA) among patients with underlying multiple sclerosis (MS) or amyotrophic lateral sclerosis (ALS). Over the course of the 12-week study in the MS patient subset, Zenvia 30/10 mg met the primary efficacy endpoint by reducing PBA episode rates by an incremental 11.9% beyond placebo

9 Oct 2009

Czura Thornton to buy MDS' Central Labs operation

MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that it has signed an agreement to sell its Central Labs operation, which conducts analysis of samples from late-stage clinical trials to Czura Thornton, a private investment group based in Jersey, Channel Islands.

From Danaher 9 Oct 2009

OncoGenex Pharmaceuticals president named Canada's Pacific Ernst & Young's Entrepreneur Of The Year

OncoGenex Pharmaceuticals, Inc., announced today that Scott Cormack, president and chief executive officer of OncoGenex, has been named Canada's Pacific Ernst & Young's Entrepreneur Of The Year(R). The Ernst & Young Entrepreneur Of The Year(R) Award is a high profile business award recognizing entrepreneurs that are building successful, dynamic businesses.

9 Oct 2009

Hepatitis A to be included in Expanded Programme on Immunization in 2010

HTDS www.htdsmedical.com (HTDS) - The issuer's China based operating subsidiary Mellow Hope www.mellowhope.com is pleased to announce the clinical protocol is in the process of being approved. It is known that the Hepatitis A will be included in the Expanded Programme on Immunization (EPI) in 2010.

9 Oct 2009

Government of Quebec develops new strategy to strengthen biopharmaceutical sectors

In the midst of challenging economic times, the announcement of the Quebec government's biopharmaceutical strategy is good news for basic pharmaceutical research and patient access to innovative medicines, said Dawn Graham, President of Merck Frosst Canada today in response to the release of the Quebec Pharmaceutical Strategy.

9 Oct 2009

First Edition: October 9, 2009 - Finance Committee still dominates news

News outlets analyzed the current political climate as the Senate Finance Committee prepares for a Tuesday vote on health overhaul legislation.

9 Oct 2009

Czura Thornton to acquire MDS's Central Labs operation

From Danaher 9 Oct 2009

National Health Care Compliance Training Week to educate healthcare organizations

Health Care Compliance Strategies, Inc. (HCCS) announced today that it will celebrate National Health Care Compliance Training Week, October 26th through November 1st, by providing free unlimited access to the HCCS Infection Control multimedia online training course and a special Expert Webinar on preventing Identity Theft in healthcare organizations.

9 Oct 2009

RXi Pharmaceuticals presents new preclinical data from its advanced RNAi therapeutic platform

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced the presentation of new preclinical data from its advanced RNAi therapeutic platform at its Annual Investor Event held in New York City on Monday, October 5, 2009.

9 Oct 2009

The Quebec Biopharmaceutical Strategy lauded by Sanofi-aventis

Sanofi-aventis Canada welcomes the Quebec Biopharmaceutical Strategy and sees a strong link with its new corporate strategy.

9 Oct 2009

Generic medicines and mail-service pharmacies are viable options for reducing health care costs

Many consumers looking for ways to reduce their health care costs are taking potentially dangerous steps such as foregoing prescription drug medications altogether or skipping necessary refills, according to a new survey from Consumer Reports.

9 Oct 2009

New soy germ-based ingredient improves menopausal symptoms

SE5-OH containing Natural S-equol, a novel soy germ-based ingredient in a supplement, improved menopausal symptoms, including significantly reducing hot flash frequency by nearly 59 percent, according to a peer-reviewed study in Japanese women.

9 Oct 2009

AHF criticizes Pfizer for its current pricing of Selzentry AIDS drug

Responding to today’s news that the Food and Drug Administration (FDA) Antiviral Advisory Committee has approved Pfizer Inc.'s AIDS therapy, Selzentry (maraviroc), for use in therapy-naïve patients, AIDS Healthcare Foundation (AHF) strongly criticized Pfizer for its current pricing of the drug at an Average Wholesale Price (AWP) of $13,767 per-patient per-year—which, if this price remains when use is expanded, would make it the most expensive first-line AIDS drug on the market.

9 Oct 2009

Educational Summit to address healthcare and pharmacies’ role in the coming years

The National Council for Prescription Drug Programs (NCPDP), a not-for-profit pharmacy standards development organization, announced its upcoming Educational Summit, Looking Ahead: Healthcare in the Next Decade, November 3, 2009 in New Orleans.

9 Oct 2009

Pharmaceuticals News and Research

Locus Pharmaceuticals enters into discovery research collaboration with Novartis

Women who take fertility drugs are at greater risk to develop thyroid cancer

Controlled trial comparing Bevacizumab to Ranibizumab finds no difference in efficacy

Riley Hospital for Children commences patient enrollment in clinical trial of cystic fibrosis drug

Health industries: Changes could kill health reform bill

CREON Delayed-Release Capsules improves fat absorption in patients with Cystic Fibrosis

Additional Zenvia Phase III results in multiple sclerosis announced by AVANIR

Czura Thornton to buy MDS' Central Labs operation

OncoGenex Pharmaceuticals president named Canada's Pacific Ernst & Young's Entrepreneur Of The Year

Hepatitis A to be included in Expanded Programme on Immunization in 2010

Government of Quebec develops new strategy to strengthen biopharmaceutical sectors

First Edition: October 9, 2009 - Finance Committee still dominates news

Czura Thornton to acquire MDS's Central Labs operation

National Health Care Compliance Training Week to educate healthcare organizations

RXi Pharmaceuticals presents new preclinical data from its advanced RNAi therapeutic platform

The Quebec Biopharmaceutical Strategy lauded by Sanofi-aventis

Generic medicines and mail-service pharmacies are viable options for reducing health care costs

New soy germ-based ingredient improves menopausal symptoms

AHF criticizes Pfizer for its current pricing of Selzentry AIDS drug

Educational Summit to address healthcare and pharmacies’ role in the coming years

Event guide: World ADC Asia eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring